Physician profile
Michael S Aronow
NPI 1457357733
$985.38
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2021: $157 · 2022: $17.91 · 2023: $194 · 2024: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $339.52 | 2019-2024 | Evos, Salto Talaris Total Ankle Prosthesis, Trigen Intertan |
| Linvatec Corporation | $159.54 | 2024 | Biobrace 23mm |
| Bone Support INC. | $128.17 | 2024 | Ceramentbone Void Filler, Cerament G |
| Globus Medical, INC. | $119.40 | 2021 | |
| Zimmer Biomet Holdings, INC. | $55.23 | 2019 | |
| Medline Industries LP | $48.95 | 2023 | |
| Davol INC. | $37.85 | 2021 | |
| Paragon 28, INC. | $36.25 | 2023 | Portfolio |
| Stryker Corporation | $21.83 | 2023 | Augment Injectable |
| Depuy Synthes Sales INC. | $21.16 | 2024 | Unium, Va-Lcp |
| Kairos Surgical INC | $17.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Aronow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.